WOC
VRTX icon

West Oak Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

West Oak Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$196 Sell
50
-2
-4% -$836 0.01% 194
2025
Q2 		$224 Hold
52
– – 0.01% 206
2025
Q1 		$243 Buy
52
+2
+4% +$932 0.01% 207
2024
Q4 		$201K Hold
50
– – 0.01% 217
2024
Q3 		$233 Hold
50
– – ﹤0.01% 210
2024
Q2 		$23.4K Hold
50
– – 0.01% 211
2024
Q1 		$21K Hold
50
– – 0.01% 207
2023
Q4 		$22K Hold
50
– – 0.01% 207
2023
Q3 		$17K Hold
50
– – 0.01% 213
2023
Q2 		$17.6K Buy
+50
New +$16.8K 0.01% 213

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return